StockData
Silo Pharma, Inc. logo

Silo Pharma, Inc. (SILO) stock

SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.71+0.14 (+8.57%)

Close on Nov 17, 2026Market cap $2.72MP/E –Yield –

Silo Pharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Silo Pharma's price to book ratio was 0.4× on Nov 11, 2026, against 1.0× a year earlier. Over the last 5 years it ranged from 0.3× to 2.3×, with a median of 0.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×−0.3
2025Dec 31, 20250.7×+0.1
2024Dec 31, 20240.6×−0.0
2023Dec 29, 20230.6×−0.3
2022Dec 30, 20220.9×−0.5
2021Dec 31, 20211.4×−16.1
2020Dec 31, 202017.5×–

More Silo Pharma figures

See a number that looks wrong?